机构：[1]The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, Liaoning Province 110001, China [2]Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China 四川大学华西医院[3]Department of Laboratory Animal Science, China Medical University, Shenyang, China [4]Department of Oncology, The Fifth Affiliated Hospital of Guangxi Medical University & The First People’s Hospital of Nanning, Nanning, Guangxi, China [5]Department of Anorectal Surgery, the First Hospital of China Medical University, Shenyang, China
National Natural Science Foundation of
China (No. 82073244, 81270036, 30901736), the Plan to Focus on
Research and Development from Science and Technology project of
Liaoning Province (No. 2017225029), Shenyang Youth Science and
Technology Innovation Talent Project (RC200267), and Natural Science Foundation of Liaoning Province (2022-MS-196).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类|2 区医学
小类|1 区药学2 区医学：研究与实验
第一作者：
第一作者机构：[1]The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, Liaoning Province 110001, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Yan Lirong,Wen Zhenpeng,Yang Yi,et al.Dissecting the roles of prosaposin as an emerging therapeutic target for tumors and its underlying mechanisms[J].BIOMEDICINE & PHARMACOTHERAPY.2024,180:117551.doi:10.1016/j.biopha.2024.117551.
APA：
Yan Lirong,Wen Zhenpeng,Yang Yi,Liu Aoran,Li Fang...&Zhang Ye.(2024).Dissecting the roles of prosaposin as an emerging therapeutic target for tumors and its underlying mechanisms.BIOMEDICINE & PHARMACOTHERAPY,180,
MLA：
Yan Lirong,et al."Dissecting the roles of prosaposin as an emerging therapeutic target for tumors and its underlying mechanisms".BIOMEDICINE & PHARMACOTHERAPY 180.(2024):117551
医学